| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Producing A Franchise Model For Franchising Nations; A Waste Of Brainpower |
|
Advice You - Producing A Franchise Model For Franchising Nations; A Waste Of Brainpower
Many people who think a lot come up with brilliant ideas and concepts. Sometimes these concepts are nice schemes fo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product r a Utopia, which does not exist and perhaps cannot exist until someone gets busy and makes it happen. Often ideas ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in are shot down using this exact argument; that they cannot exist because the World is already the way it is. Other i lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. eas are shot down for fundamental reasons such as who will sign onto the idea? Who will sell it and market it and m here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ost of all who will buy it. So then the concept of franchising nations using a winning model makes sense and that d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro is a given, but say critics who will buy it? Are there any prospective buyers out there, such as third world nation ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc wishing to upgrade? Critics also might say if there are no buyers then even spending time thinking about it is a h easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi uge waste of brainpower. I disagree, no it is not a terrible waste of brain power and I have already put in 90% of nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically it, besides the United Nations is having issues as Trading Partners are willing to forgo their integrity and risk and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ orld Catastrophe, simple to sell WMD. And this International Terrorist thing; although in reality mostly sound and ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi fury, is truly unacceptable. Prospects are everywhere as Nations Governments crumble under their own mismanagement ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a , greed or organization structure and organizational capital due to paranoia and outside influences. Look at Boliva dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mistakes, who will bail them out, and really who wants too? Debtor nations are too common and throwing good money cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin after bad only to watch it leave the country and flow out as fast as it is put in, until a new government comes in tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen because the old one never even understood the game. The old government defaults and the new government says give u t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel another chance? Personally, I understand the shell game, but it makes sense to grow the pie bigger so everyone win ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust s. Additionally, when you have counties like Lebanon and perhaps future countries like the Palestinian Authority t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products hen they are potential buyers of to become a nation franchisee of the World Franchise System and thus it is not onl . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de a good use of brain power, it opens the door to endless opportunities to promote; Peace, Freedom and Liberty and l elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ast time I checked those were are highly sought after conditions for human civilizations. Consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Real Time Futures - Why It Should Impact Your Futures Broker Decision Fly High With A Custom Imprinted Promotional Advertising Balloon Corporate Gifts with Logo is Mileage for Money
|